NEU 2.14% $1.43 neuren pharmaceuticals limited

Goldman Sachs Healthcare Conference

  1. 424 Posts.
    lightbulb Created with Sketch. 50
    FYI - Acadia presented at GS healthcare conference overnight.
    Whilst most of their half hour slot was on Nuplazid, the last couple of minutes were discussing the Retts syndrome compound.

    Gives some really nice context to the deal from an Acadia business development perspective. Its the kind of compound that aligns to where they want to head with the business.

    Also hints that there will be more deals such as the trof one in the near future. - read into that what you will - however if this is the sort of compound they want to go after - boy how about 2591.

    You can listen in here ->

    https://event.webcasts.com/starthere.jsp?ei=1247214&tp_key=469ab66e49


 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$1.43
Change
0.030(2.14%)
Mkt cap ! $143.7M
Open High Low Value Volume
$1.45 $1.45 $1.41 $25.49K 18.09K

Buyers (Bids)

No. Vol. Price($)
1 2000 $1.41
 

Sellers (Offers)

Price($) Vol. No.
$1.44 9750 1
View Market Depth
Last update - 15.37pm 24/07/2019 (20 minute delay) ?
(live)
Last
$1.40
  Change
0.030 ( 0.00 %)
Open High Low Volume
$1.43 $1.43 $1.40 3764
Last updated 14.01pm 24/07/2019 (live) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.